172 related articles for article (PubMed ID: 17000390)
1. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
Boughey JC; Bedrosian I; Meric-Bernstam F; Ross MI; Kuerer HM; Akins JS; Giordano SH; Babiera GV; Ames FC; Hunt KK
J Am Coll Surg; 2006 Oct; 203(4):475-80. PubMed ID: 17000390
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy in male patients with early breast cancer.
Gentilini O; Chagas E; Zurrida S; Intra M; De Cicco C; Gatti G; Silva L; Renne G; Cassano E; Veronesi U
Oncologist; 2007 May; 12(5):512-5. PubMed ID: 17522237
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in patients with male breast carcinoma.
Port ER; Fey JV; Cody HS; Borgen PI
Cancer; 2001 Jan; 91(2):319-23. PubMed ID: 11180077
[TBL] [Abstract][Full Text] [Related]
4. Is breast cancer sentinel lymph node mapping valuable for patients in their seventies and beyond?
McMahon LE; Gray RJ; Pockaj BA
Am J Surg; 2005 Sep; 190(3):366-70. PubMed ID: 16105520
[TBL] [Abstract][Full Text] [Related]
5. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
Hwang RF; Gonzalez-Angulo AM; Yi M; Buchholz TA; Meric-Bernstam F; Kuerer HM; Babiera GV; Tereffe W; Liu DD; Hunt KK
Cancer; 2007 Aug; 110(4):723-30. PubMed ID: 17587208
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
7. Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
Thomas KA; Lechner J; Shen P; Waters GS; Geisinger KR; Levine EA
Am Surg; 2006 Jul; 72(7):606-11; discussion 611-2. PubMed ID: 16875082
[TBL] [Abstract][Full Text] [Related]
8. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.
Port ER; Garcia-Etienne CA; Park J; Fey J; Borgen PI; Cody HS
Ann Surg Oncol; 2007 Aug; 14(8):2209-14. PubMed ID: 17268882
[TBL] [Abstract][Full Text] [Related]
9. Prediction of sentinel lymph node-only disease in women with invasive breast cancer.
Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
Am J Surg; 2006 Dec; 192(6):882-7. PubMed ID: 17161113
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant systemic therapy for male breast carcinoma.
Giordano SH; Perkins GH; Broglio K; Garcia SG; Middleton LP; Buzdar AU; Hortobagyi GN
Cancer; 2005 Dec; 104(11):2359-64. PubMed ID: 16270318
[TBL] [Abstract][Full Text] [Related]
11. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
12. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
[TBL] [Abstract][Full Text] [Related]
13. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
[TBL] [Abstract][Full Text] [Related]
14. Her-2/neu expression in primary breast cancer with sentinel lymph node metastasis.
Nathanson SD; Slater R; Debruyn D; Kapke A; Linden M
Ann Surg Oncol; 2006 Feb; 13(2):205-13. PubMed ID: 16408141
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
16. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
17. Paradigm shift of staging and treatment for early breast cancer in the sentinel lymph node era.
Leong SP
Breast J; 2006; 12(5 Suppl 2):S128-33. PubMed ID: 16958992
[TBL] [Abstract][Full Text] [Related]
18. Are 3 sentinel nodes sufficient?
Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
Arch Surg; 2007 May; 142(5):456-9; discussion 459-60. PubMed ID: 17515487
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of sentinel lymph node in papillary thyroid carcinoma.
Arch-Ferrer J; Velázquez D; Fajardo R; Gamboa-Domínguez A; Herrera MF
Surgery; 2001 Dec; 130(6):907-13. PubMed ID: 11742316
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.
Cserni G; Bianchi S; Vezzosi V; Arisio R; Bori R; Peterse JL; Sapino A; Drijkoningen M; Kulka J; Eusebi V; Foschini MP; Bellocq JP; Marin C; Thorstenson S; Amendoeira I; Reiner-Concin A; Decker T
Eur J Cancer; 2007 Jun; 43(9):1407-14. PubMed ID: 17531465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
